Holdings
GordonMD Global Investments LP
As of Jun 30, 2026, GordonMD Global Investments LP reported 16 positions worth US$207M. Largest: Kyverna Therapeutics, Inc., Pyxis Oncology, Inc. and Taysha Gene Therapies, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Kyverna Therapeutics, Inc. | 4.24M | US$37.8M | no change | Jun 30, 2026 |
| Pyxis Oncology, Inc. | 10M | US$30.2M | +5.9M | Jun 30, 2026 |
| Taysha Gene Therapies, Inc. | 723K | US$24.5M | −14,365 | Jun 30, 2026 |
| Teva Pharmaceutical Industries Limited | 2.4M | US$16.4M | +1.15M | Jun 30, 2026 |
| Vir Biotechnology, Inc. | 1.35M | US$13.8M | −165K | Jun 30, 2026 |
| Allogene Therapeutics, Inc. | 5.3M | US$11M | +3.87M | Jun 30, 2026 |
| Celldex Therapeutics, Inc. | 280K | US$10.4M | +109K | Jun 30, 2026 |
| Editas Medicine, Inc. | 3.13M | US$10.1M | new | Jun 30, 2026 |
| Ultragenyx Pharmaceutical Inc. | 289K | US$9.65M | no change | Jun 30, 2026 |
| Bausch + Lomb Corporation | 573K | US$9.5M | no change | Jun 30, 2026 |